Johnson & Johnson (LIM:JNJ) Research & Development: $14,967 Mil (TTM As of Mar. 2026)


LIM:JNJ Johnson & Johnson LIM:JNJ
85 GF Score
Price $220.00
GF Value $171.21
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Research & Development?

Johnson & Johnson LIM:JNJ 85 Research & Development is $14,967 Mil as of Mar. 2026. GuruFocus rates LIM:JNJ with a GF Score™ of 85/100 and a GF Value™ of $171.21. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Johnson & Johnson's Research & Development for the three months ended in Mar. 2026 was $3,527 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $14,967 Mil.

Johnson & Johnson  (LIM:JNJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Johnson & Johnson Research & Development Related Terms

Johnson & Johnson Research & Development Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Research & Development Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,277.00 14,135.00 15,085.00 17,232.00 14,665.00

Johnson & Johnson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,225.00 3,516.00 3,672.00 4,252.00 3,527.00
LIM:JNJ
85GF Score
Johnson & Johnson LIM:JNJ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14,967 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $14,967 Mil mean?
Johnson & Johnson (LIM:JNJ) has a Research & Development of $14,967 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Research & Development too high?
Johnson & Johnson's current Research & Development is $14,967 Mil. Overall, Johnson & Johnson has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Research & Development compare to ABBV and MRK?
Johnson & Johnson's Research & Development of $14,967 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Research & Development is $14,967 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Johnson & Johnson (LIM:JNJ) has a current Research & Development of $14,967 Mil. The stock's GF Value™ is $171.21, compared to a current price of $220.00 — trading 28.5% above its estimated fair value. The current Research & Development is $14,967 Mil. Johnson & Johnson's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Johnson & Johnson (LIM:JNJ), the current Research & Development is $14,967 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (LIM:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $220.00 is trading 28.5% above its estimated GF Value™ of $171.21.

Key valuation signals for LIM:JNJ:

  • Research & Development: $14,967 Mil
  • GF Value™: $171.21 vs. price of $220.00 (28.5% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the LIM:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for LIM:JNJ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$220.00
Price
$171.21
GF Value